NCT07428642 2026-03-18
PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.
First Affiliated Hospital of Wenzhou Medical University
Completed
Clinical Trials
1,599 trialsNCT04037254 2026-03-16
Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring
NRG Oncology
Phase 1/2 Completed
NCT01596816 2026-03-13
CKNO-PRO
Centre Oscar Lambret
Phase 2 Completed
NCT01804712 2026-03-12
Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy
University of California, San Diego
Phase EARLY_PHASE1 Completed
NCT07464964 2026-03-11
MUSIC-PRT
Dokuz Eylul University
Phase NA Completed
NCT05162846 2026-03-09
MiGHT
University of Michigan Rogel Cancer Center
Phase NA Completed
NCT00160979 2026-03-06
Transrectal Tumour Oxygen - US Army
University Health Network, Toronto
Phase 2 Completed
NCT01567800 2026-03-06
Prostate Hypoxia FAZA
University Health Network, Toronto
Phase NA Completed
NCT05764005 2026-03-06
Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study
University of Michigan Rogel Cancer Center
Phase NA Completed
NCT06184867 2026-03-06
CATALYST
Rutgers, The State University of New Jersey
Phase NA Completed
NCT05008900 2026-03-05
TOPP
University Health Network, Toronto
Phase 2 Completed
NCT06472856 2026-03-04
VASA Pro
University College Cork
Phase NA Completed
NCT05700903 2026-03-02
ARCH
University of Colorado, Denver
Phase 4 Completed
NCT04443062 2026-02-27
Bullseye
Radboud University Medical Center
Phase 2 Completed
NCT03159676 2026-02-25
Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer
Mayo Clinic
Completed
NCT03568188 2026-02-24
FOCALE
Hospices Civils de Lyon
Phase 2 Completed
NCT02899221 2026-02-20
Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation
Thomas Jefferson University
Phase NA Completed
NCT04461509 2026-02-20
High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy
Cedars-Sinai Medical Center
Phase 2 Completed
NCT04815876 2026-02-20
PREVENT2
Weill Medical College of Cornell University
Phase NA Completed
NCT00809991 2026-02-18
Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT04048252 2026-02-18
PROSTED
Centre Hospitalier Universitaire de Nīmes
Completed
NCT07416812 2026-02-18
IMPACT
Institute of Oncology Ljubljana
Phase NA Completed
NCT07417475 2026-02-18
Robot-Assisted Radical Prostatectomy: the HOOD Technique Versus Standard Anterior Reconstruction
Ankara University
Phase NA Completed
NCT02776436 2026-02-17
REDEX
Leiden University Medical Center
Phase 1 Completed
NCT03421782 2026-02-17
Fatigue Interventions in Cancer (Exercise Intervention)
University of Utah
Phase 2 Completed
NCT06661902 2026-02-17
BURN
University of Washington
Phase 1/2 Completed
NCT07413120 2026-02-17
Efficacy and Safety of VasoClip® vs. WeckClip® for Robotic Urologic Surgery
Incheon St.Mary's Hospital
Phase 3 Completed
NCT01543659 2026-02-13
Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT02274779 2026-02-13
OLIGOPELVIS
Institut Cancerologie de l'Ouest
Phase 2 Completed
NCT02313623 2026-02-12
MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research
Yale University
Completed
NCT06253065 2026-02-11
Prospective Validation of Pathology-based Artificial Intelligence Diagnostic Model for Lymph Node Metastasis in Prostate Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Completed
NCT05730712 2026-02-06
Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer
Mayo Clinic
Phase 2 Completed
NCT00893035 2026-02-05
Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients
Institut du Cancer de Montpellier - Val d'Aurelle
Completed
NCT04484246 2026-02-04
HoSAGE
Assistance Publique Hopitaux De Marseille
Completed
NCT06379880 2026-02-04
FEGALA
Centre Paul Strauss
Phase NA Completed
NCT06764992 2026-02-04
Exploring Men s Prostate Cancer Genetic Risk Perceptions
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT03535831 2026-02-03
PM-PPR
University Health Network, Toronto
Phase NA Completed
NCT02772588 2026-01-27
AASUR in High Risk Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT05011799 2026-01-27
The Peer Genetic Study
Thomas Jefferson University
Phase NA Completed
NCT03565835 2026-01-26
Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer
Montefiore Medical Center
Phase 2 Completed
NCT04782713 2026-01-22
Smart Prostate Specific Antigen (PSA) Screening Study
University of Illinois at Chicago
Phase NA Completed
NCT05470036 2026-01-16
IMPRINT
University of California, San Diego
Phase NA Completed
NCT03556904 2026-01-15
FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT04763824 2026-01-14
KANSURVIVE
University of Kansas Medical Center
Phase NA Completed
NCT00186368 2026-01-12
Microarray Analysis of Gene Expression in Prostate Tissues
Stanford University
Completed
NCT07333807 2026-01-12
Efficacy of the Pelvic Clock® Device for Functional Recovery After Robotic-Assisted Radical Prostatectomy
Tri-Service General Hospital
Phase NA Completed
NCT07331246 2026-01-09
TENS for Pain Relief During Fusion-Guided Prostate Biopsy
Medical University of Gdansk
Phase NA Completed
NCT02189486 2026-01-07
Prostate Cancer Upgrading Reference Set
The University of Texas Health Science Center at San Antonio
Completed
NCT03734757 2026-01-02
DEMETER
Centre Henri Becquerel
Phase NA Completed
NCT06016725 2026-01-02
E-PROOF
Ohio State University Comprehensive Cancer Center
Phase NA Completed